The MET pathway is involved in normal cellular processes such as growth, survival, and tissue repair. However, in cancer, mutations, amplifications, or overexpression of MET can lead to uncontrolled cell proliferation and survival. This makes MET a critical target for cancer therapy, particularly in cancers where MET dysregulation is prevalent.
